Skip to content

13F-HR filed by COURAGE CAPITAL MANAGEMENT LLC

COURAGE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 20 holding rows worth $149,483,000.

Accession
0001140361-17-042663
Filed
2017-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 20 entries on the cover page, a total value of $149,483,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $149,483,000 with VALUE read as thousands by filing date, 13F file number 028-10362. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALTABA INC021346101COM1,400,000$92,736,000thousands by filing date
iShares Russell 2000 ETF464287655SHS120,000$17,782,000thousands by filing date
VEREIT INC92339V100COM1,650,000$13,679,000thousands by filing date
Alphabet Inc. Reg. Shares C02079K107COM8,500$8,152,000thousands by filing date
SPDR GOLD TR78463V107GOLD SHS23,625$2,872,000thousands by filing date
MICHAEL KORS HLDGS LTDG60754101SHS50,000$2,393,000thousands by filing dateput
FIESTA RESTAURANT GROUP INC31660B101COM112,925$2,146,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR45,000$1,910,000thousands by filing date
META PLATFORMS INC CL A30303M102COM9,000$1,538,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS75,000$1,489,000thousands by filing date
VANECK ETF TRUST92189F106GOLD MINERS ETF56,400$1,295,000thousands by filing date
CONATUS PHARMACEUTICALS INC20600T108COM200,000$1,098,000thousands by filing date
DSW INC-CLASS A23334L102CL A25,000$537,000thousands by filing datecall
Vanguard Intermediate-Term Corporate Bond ETF92206C870SHS5,600$493,000thousands by filing date
Walmart Inc.931142103COM5,550$434,000thousands by filing date
SPY78462F103SHS1,194$300,000thousands by filing date
GALECTIN THERAPEUTICS INC363225202COMMON STOCK130,000$278,000thousands by filing date
WEB COM GROUP INC94733AAA2NOTE 1.000% 8/1250,000$248,000thousands by filing dateprincipal
IMMURON LTD45254U101SPONSORED ADR10,000$53,000thousands by filing date
IMMURON LTDQ4867H223*W EXP 06/08/20245,297$50,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-17-042663this filing2017-11-14acceptance time not in the bulk data set